A major breakthrough in cancer research is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in several types of malignancies, https://bookmarkcitizen.com/story21928103/nanobodies-restore-the-p53-protein-the-promising-approach-for-tumor-management